Enhanced phototoxicity and specificity of AlPCS4 when loaded in liposomes conjugated with a MET-targeting nanobody

Bárbara Mesquita¹, Michal Heger^1,2,3, Sabrina Oliveira^1,4

¹Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands; ²Jiaxing Key Laboratory for Photonanomedicine and Experimental Therapeutics, Department of Pharmaceutics, Jiaxing University, College of Medicine, Jiaxing, Zhejiang, P. R. China; ³Membrane Biochemistry and Biophysics, Bijvoet Center for Biomolecular Research, Department of Chemistry, Utrecht University, Utrecht, the Netherlands; ⁴Cell Biology, Neurobiology and Biophysics, Department of Biology, Science Faculty, Utrecht University, Utrecht, the Netherlands

Liposomes with free- and lipid-conjugated verteporfin: Combining light-controlled drug delivery, photodynamic therapy, and increased tumor permeability

Tristan Le Clainche¹, Nazareth Milagros Carigga-Gutierrez¹, Núria Pujol-Solé¹, Chanda Bhandari², Malika Kadri¹, Maxime Henry¹, Véronique Josserand¹, Jean-Luc Coll¹, Obaid Girgis², Mans Broekgaarden¹

¹Institute for Advanced Biosciences, INSERM U1209, CNRS UMR 5309, Grenoble-Alpes University, Grenoble, France.; ²Department of Bioengineering, University of Texas at Dallas, Richardson TX, United States

A Lock-and-Kill Anticancer Photoactivated Chemotherapy Agent

Sina Katharina Goetzfried¹, Erik van Geest¹, David Klein¹, Nathalia Salitra¹, Soraya Popal¹, Yurii Husiev¹, Corjan van der Griend¹, Xuequan Zhou¹, Maxime Siegler², Gregory Schneider¹, Sylvestre Bonnet¹

¹Leiden University, Netherlands, The; ²Small Molecule X-ray Facility, John Hopkins University, Baltimore, MD

Porphysome Nanotechnology: From Discovery toward First-in-Patients

Gang Zheng

Princess Margaret Cancer Centre, Canada

PDT and RNA medicine combination therapies for pancreatic ductal adenocarcinoma

Vida Karimnia¹, Shakir Khan¹, Mark Woodnorth¹, Frank Slack², Jonathan Celli¹

¹University of Massachusetts Boston, Boston, MA USA; ²Beth Israel Deaconess Medical Center, Boston, MA USA

Light-enhanced VEGF121/rGel induce immunogenic cell death and increase the antitumor activity of αCTLA4 treatment

Anette Weyergang, Ane Longva, Kristian Berg

Oslo University Hospital, Norway

A Targeted Photo-Activable Multi-Inhibitor Liposomes (TPMILs) with fixed-ratio drug combination for ovarian cancer

Payal Srivastava¹, Huang-Chiao Huang^1,2

¹Fischell Department of Bioengineering, University of Maryland, College Park, MD 20742, USA; ²Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD 21201, USA

Development of Self-Activated Photosensitizers based on the Chemiluminescent System of Marine Coelenterazine

Luís Pinto da Silva, Carla Magalhães, Patricia González-Berdulals, Joaquim Esteves da Silva

University of Porto - Faculty of Sciences, Portugal